Demographic, ethnic, and geographic differences between human T cell lymphotropic virus (HTLV) type I-seropositive carriers and persons with HTLV- I Gag-indeterminate western blots in Central Africa

Journal of Infectious Diseases

Volumn 176, Issue 2, 1997, Pages 505-509

  Mauclère, Philippe ^b   Le Hesran, Jean Yves ^b   Mahieux, Renaud ^b   Salla, Roger ^b   Mfoupouendoun, Jermie ^b   Abada, Emmanuel Tina ^b   Millan, Jacques ^b   De Thé, Guy ^b   Gessain, Antoine ^a  

^a Institut Pasteur   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CAMEROON; CENTRAL AFRICA; CHILD; ENVIRONMENTAL FACTOR; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RURAL AREA;

EID: 0030855431     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514071     Document Type: Article

References (16)

1. Gessain A, Mahieux R, de Thé G. HTLV-I "indeterminate" Western blot patterns observed in sera from tropical regions: the situation revisited. J Acquir Immune Defic Syndr Hum Retrovirol 1995;9:316-9.
2. Biggar RJ, Gigase PL, Melbye M, et al. ELISA HTLV retrovirus antibody reactivity associated with malaria and immune complexes in healthy Africans. Lancet 1985;2:520-3.
3. Biggar RJ, Neequaye JE, Neequaye AR, et al. The prevalence of antibodies to the human T lymphotropic virus (HTLV) in Ghana, West Africa. AIDS Res Hum Retroviruses 1993;9:505-11.
4. Biggar RJ, Saxinger C, Gardiner C, et al. Type-I HTLV antibody in urban and rural Ghana, West Africa. Int J Cancer 1984;34:215-9.
5. Bonis J, Preux PM, Nzisabira L, et al. HTLV-I in Burundi (east Africa): lack of reactivity to the HTLV-I immunodominant envelope epitope. J Acquir Immune Defic Syndr 1994;7:1099-100.
6. De Thé G, Gessain A, Gazzolo L, et al. Comparative seroepidemiology of HTLV-I and HTLV-II in the French West Indies and some Africa countries. Cancer Res 1985;45:4633-6.
7. Delaporte E, Peeters M, Durand JP, et al. Seroepidemiological survey of HTLV-I infection among randomized populations of western central African countries. J Acquir Immune Defic Syndr 1989;2:410-3.
8. Louis JP, Gardon J, Trebucq A, et al. Particularités épidémiologiques de l'infection rétrovirale à HTLV-I en Afrique Centrale. Bull Soc Pathol Exot 1993;86:163-8.
9. Hayes CG, Burans JP, Oberst RB. Antibodies to human T lymphotropic virus type I in a population from the Philippines: evidence for cross-reactivity with Plasmodium falciparum. J Infect Dis 1991; 163:257-62.
10. Lal RB, Rudolph D, Alpers M P, Sulzer AJ, Ya-Ping S, Lai AA. immunologic cross-reactivity between structural proteins of human T-cell lymphotropic virus type I and the blood stage of Plasmodium falciparum. Clin Diagn Lab Immunol 1994;1:5-10.
11. Lal RB, Rudolph DL, Coligan JE, Brodine SK, Roberts CR. Failure to detect evidence of human T-lymphotropic virus (HTLV) type I and type II in blood donors with isolated gag antibodies to HTLV-I/II. Blood 1992;80:544-50.
12. Lipka JJ, Young KK, Kwok SY, Reyes GR, Sninsky JJ, Foung SK. Significance of human T-lymphotropic virus type I indeterminant serological findings among healthy individuals. Vox Sang 1991;61:171-6.
13. Khabbaz R, Heinene W, Grindon A, Hartley TM, Shulman G, Kaplan J. Indeterminate HTLV serologic results in US blood donors: are they due to HTLV-I or HTLV-II? J Acquir Immune Defic Syndr 1992;5:400-4.
14. Nerurkar VR, Miller MA, Leon-Monzon ME, et al. Failure to isolate human T cell lymphotropic virus type I and to detect variant-specific genomic sequences by polymerase chain reaction in Melanesians with indeterminate Western immunoblot. J Gen Virol 1992;73:1805-10.
15. North ML, Lemaire JM, Couroucé AM, et groupe de travail "Retrovirus" de la Société Française de Transfusion Sanguine, les tests de dépistage des anticorps anti-HTLV en 1995. Spectra Biologie 1995;95:47-53.
16. Banki K, Maceda J, Hurley E, et al. Human T-cell lymphotropic virus (HTLV)-related endogenous sequence, HRES-1, encodes a 28-kDa protein: a possible autoantigen for HTLV-I gag-reactive autoantibodies. Proc Natl Acad Sci USA 1992;89:1939-43.